Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Open-Label, Expanded Access Study of Taliglucerase Alfa in Patients with Gaucher Disease Requiring Enzyme Replacement Therapy

David J. Kuter, MD DPhil, Michael Wajnrajch, MD MPA, Betina Hernandez, MD, Rong Wang, MPH, Raul Chertkoff, MD MBA, Ari Zimran, MD

Blood (2018) 132 (Supplement 1): 3755.

https://doi.org/10.1182/blood-2018-99-112660

Published: 2018

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

David J. Kuter, MD DPhil, Richy Agajanian, MD, Donald M. Arnold, MD MSc, FRCPC, Michael Boxer, MD, Catherine Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Kerry A. Rogers, MD, Ann M Lowe, MD, Sandra Tong, MD, Hany Zayed, PhD, Anne-Marie Duliege, MD MS

Blood (2018) 132 (Supplement 1): 3612.

https://doi.org/10.1182/blood-2018-99-110483

Published: 2018

Journal Articles

Thrombopoietin Level Predicts Response to Treatment with Eltrombopag and Romiplostim in Immune Thrombocytopenia

Hanny Al-Samkari, MD, David J. Kuter, MD DPhil

Blood (2018) 132 (Supplement 1): 734.

https://doi.org/10.1182/blood-2018-99-117267

Published: 2018

Journal Articles

Assessment of Romiplostim Immunogenicity in Adult Patients in Clinical Trials and in a Global Registry

Troy E. Barger, BSc, Andy Boshier, MBChB, MSc, Vibha Jawa, PhD, June Kim, PhD, Daniel T. Mytych, PhD, Joseph Park, MD PhD, David J. Kuter, MD DPhil

Blood (2018) 132 (Supplement 1): 2427.

https://doi.org/10.1182/blood-2018-99-113484

Published: 2018

Journal Articles

Antiplatelet Antibody Testing in Immune Thrombocytopenia and Evans Syndrome: Longitudinal Serologic Evolution and Relation to Clinical Features

Hanny Al-Samkari, MD, David J. Kuter, MD DPhil

Blood (2018) 132 (Supplement 1): 1137.

https://doi.org/10.1182/blood-2018-99-118403

Published: 2018

Journal Articles

Systemic Bevacizumab for the Treatment of Chronic Bleeding in Hereditary Hemorrhagic Telangiectasia

Hanny Al-Samkari, MD, Athena Kritharis, MD, Josanna Rodriguez-Lopez, MD, David J. Kuter, MD DPhil

Blood (2018) 132 (Supplement 1): 852.

https://doi.org/10.1182/blood-2018-99-117144

Published: 2018

Journal Articles

Absence of Plasma Gastric Biomarker Elevations with Chronic Dosing of Avatrombopag, a Novel Oral Thrombopoietin Receptor Agonist, in Patients with Chronic Immune Thrombocytopenia in Phase 3 Trials

James B. Bussel, MD, Lee F. Allen, MD PhD, Wei Tian, PhD, David J. Kuter, MD DPhil

Blood (2018) 132 (Supplement 1): 3740.

https://doi.org/10.1182/blood-2018-99-116873

Published: 2018

Journal Articles

Healthcare Resource Utilization and Costs Associated with Different Treatment Modalities of Relapsed/Refractory Multiple Myeloma Patients in the US: Findings from Preamble

David J Kuter, MD DPhil, Clara Chen, PhD BS, MS, Sergey Popov, Catherine Davis, Ravi Vij, MD MBBS

Blood (2017) 130 (Supplement 1): 3157.

https://doi.org/10.1182/blood.V130.Suppl_1.3157.3157

Published: 2017

Journal Articles

Comparison of the Effects of the Thrombopoietin (TPO) Receptor Agonist Romiplostim in Patients with Immune Thrombocytopenia (ITP) for ≤1 Year Vs. >1 Year

David J Kuter, MD DPhil, Adrian Newland, Beng H Chong, MBBS, PhD, Francesco Rodeghiero, MD, Monica Tejeda Romero, Ingrid Pabinger, MD, Yuqi Chen, Kejia Wang, Bhakti Mehta, Melissa Eisen

Blood (2017) 130 (Supplement 1): 1055.

https://doi.org/10.1182/blood.V130.Suppl_1.1055.1055

Published: 2017

Journal Articles

Romiplostim for the Management of Perioperative Thrombocytopenia

Hanny Al-Samkari, MD, Ariela L. Marshall, MD, Katayoon Goodarzi, MD, David J Kuter, MD DPhil

Blood (2017) 130 (Supplement 1): 1037.

https://doi.org/10.1182/blood.V130.Suppl_1.1037.1037

Published: 2017

Journal Articles

Patient-Reported Symptom Burden and Peripheral Blood Counts Among Patients with Polycythemia Vera: An Analysis from the Reveal Study

Michael Richard Grunwald, MD, John M. Burke, MD, David J Kuter, MD DPhil, Aaron T. Gerds, MDMS, Brady Lee Stein, MD MHS, Michael R. Savona, MD, Mark A. Walshauser, MD, Ahmad B. Naim, MD, Philomena Colucci, DO, MS, Dilan Chamikara Paranagama, PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 2924.

https://doi.org/10.1182/blood.V130.Suppl_1.2924.2924

Published: 2017

Journal Articles

Superiority of Avatrombopag to Placebo in Increasing Platelet Counts in Patients with Chronic Liver Disease-Associated Thrombocytopenia Undergoing Scheduled Procedures: Results from 2, Phase 3 Randomized Studies

Norah Terrault, MD MPH, David J Kuter, MD DPhil, Namiki Izumi, MD PhD, Zeid Kayali, MD, Paul Mitrut, MD PhD, Won Young Tak, MD, Francesco Bibbiani, MD

Blood (2017) 130 (Supplement 1): 18.

https://doi.org/10.1182/blood.V130.Suppl_1.18.18

Published: 2017

Journal Articles

Examining the Treatment Patterns and Blood Counts Among Patients with Polycythemia Vera Treated with Hydroxyurea in the United States: An Analysis from the Reveal Study

Michael Richard Grunwald, MD, Ivy Altomare, MD, John M. Burke, MD, Aaron T. Gerds, MDMS, Mark A. Walshauser, MD, Michael R. Savona, MD, David J Kuter, MD DPhil, Brady Lee Stein, MD MHS, Stephen Oh, MD PhD, Philomena Colucci, DO, MS, Ahmad B. Naim, MD, Dilan Chamikara Paranagama, PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 1633.

https://doi.org/10.1182/blood.V130.Suppl_1.1633.1633

Published: 2017

Journal Articles

Markers of Autoimmunity in Immune Thrombocytopenia: Prevalence and Prognostic Significance

Marie A Hollenhorst, MD PhD, David J Kuter, MD DPhil

Blood (2016) 128 (22): 1363.

https://doi.org/10.1182/blood.V128.22.1363.1363

Published: 2016

Journal Articles

A Global Delphi Consensus Initiative for Early Diagnosis of Gaucher Disease: Barriers, Their Resolution and the Impact on Patients

David J Kuter, MD DPhil, Sam Salek, PhD, Atul Mehta, MD

Blood (2016) 128 (22): 4885.

https://doi.org/10.1182/blood.V128.22.4885.4885

Published: 2016

Journal Articles

Key Presenting Signs and Patient Co-Variables in Early Diagnosis of Type 3 Gaucher Disease: A Global Delphi Consensus Initiative

David J Kuter, MD DPhil, Sam Salek, PhD, Atul Mehta, MD

Blood (2016) 128 (22): 4886.

https://doi.org/10.1182/blood.V128.22.4886.4886

Published: 2016

Journal Articles

Safety and Efficacy of PRTX-100, a Highly Purified Form of Staphylococcal Protein A, in Patients with Immune Thrombocytopenia (ITP)

James B. Bussel, MD, David J Kuter, MD DPhil, Sylvain Audia, MD PhD, Richard J. Francovitch, PhD, Marc Michel, MD PhD

Blood (2016) 128 (22): 4929.

https://doi.org/10.1182/blood.V128.22.4929.4929

Published: 2016

Journal Articles

An Ongoing, Observational Cohort Study in Multiple Myeloma (PREAMBLE): Preliminary Efficacy Analyses in Patients with 1 Line of Prior Therapy

Brian Durie, MD, David J Kuter, MD DPhil, Catherine Davis, Teresa Zyczynski, PharmD, MPH, MBA, BSPharm, Hartmut Goldschmidt, Ravi Vij, Sergey Popov, David Cella, PhD, Gordon Cook, MD PhD

Blood (2016) 128 (22): 2403.

https://doi.org/10.1182/blood.V128.22.2403.2403

Published: 2016

Journal Articles

FF-10102-01: A Novel, Highly Selective Spleen Tyrosine Kinase Inhibitor, to Be in Clinical Application for Treatment of Autoimmune Diseases and B-Cell Malignancies

Chieko Kinouchi, Kazuya Taguchi, Susumu Shimoyama, Tadaaki Ioroi, DPhil, Hayato Ogura, Mari Yamamoto, Akiko Iino, Yoshimasa Maeda, DPhil, Hiroshi Kato, Hideyasu Fujiwara, DPhil, Shinji Hagiwara, DPhil, Hiroyuki Iwamura, Dphil, David J Kuter, MD DPhil, Takaaki Nakamura, DPhil, Yasuhiro Shimada

Blood (2016) 128 (22): 3745.

https://doi.org/10.1182/blood.V128.22.3745.3745

Published: 2016

Journal Articles

Romiplostim for Treatment and Prevention of Chemotherapy-Associated Thrombocytopenia

Hanny Al-Samkari, MD, David J Kuter, MD DPhil, Katayoon Goodarzi, MD, Ariela L. Marshall, MD

Blood (2016) 128 (22): 3748.

https://doi.org/10.1182/blood.V128.22.3748.3748

Published: 2016

NARROW

Open-Label, Expanded Access Study of Taliglucerase Alfa in Patients with Gaucher Disease Requiring Enzyme Replacement Therapy

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

Thrombopoietin Level Predicts Response to Treatment with Eltrombopag and Romiplostim in Immune Thrombocytopenia

Assessment of Romiplostim Immunogenicity in Adult Patients in Clinical Trials and in a Global Registry

Antiplatelet Antibody Testing in Immune Thrombocytopenia and Evans Syndrome: Longitudinal Serologic Evolution and Relation to Clinical Features

Systemic Bevacizumab for the Treatment of Chronic Bleeding in Hereditary Hemorrhagic Telangiectasia

Absence of Plasma Gastric Biomarker Elevations with Chronic Dosing of Avatrombopag, a Novel Oral Thrombopoietin Receptor Agonist, in Patients with Chronic Immune Thrombocytopenia in Phase 3 Trials

Healthcare Resource Utilization and Costs Associated with Different Treatment Modalities of Relapsed/Refractory Multiple Myeloma Patients in the US: Findings from Preamble

Comparison of the Effects of the Thrombopoietin (TPO) Receptor Agonist Romiplostim in Patients with Immune Thrombocytopenia (ITP) for ≤1 Year Vs. >1 Year

Romiplostim for the Management of Perioperative Thrombocytopenia

Patient-Reported Symptom Burden and Peripheral Blood Counts Among Patients with Polycythemia Vera: An Analysis from the Reveal Study

Superiority of Avatrombopag to Placebo in Increasing Platelet Counts in Patients with Chronic Liver Disease-Associated Thrombocytopenia Undergoing Scheduled Procedures: Results from 2, Phase 3 Randomized Studies

Examining the Treatment Patterns and Blood Counts Among Patients with Polycythemia Vera Treated with Hydroxyurea in the United States: An Analysis from the Reveal Study

Markers of Autoimmunity in Immune Thrombocytopenia: Prevalence and Prognostic Significance

A Global Delphi Consensus Initiative for Early Diagnosis of Gaucher Disease: Barriers, Their Resolution and the Impact on Patients

Key Presenting Signs and Patient Co-Variables in Early Diagnosis of Type 3 Gaucher Disease: A Global Delphi Consensus Initiative

Safety and Efficacy of PRTX-100, a Highly Purified Form of Staphylococcal Protein A, in Patients with Immune Thrombocytopenia (ITP)

An Ongoing, Observational Cohort Study in Multiple Myeloma (PREAMBLE): Preliminary Efficacy Analyses in Patients with 1 Line of Prior Therapy

FF-10102-01: A Novel, Highly Selective Spleen Tyrosine Kinase Inhibitor, to Be in Clinical Application for Treatment of Autoimmune Diseases and B-Cell Malignancies

Romiplostim for Treatment and Prevention of Chemotherapy-Associated Thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only